Apolipoprotein(a) isoforms and coronary heart disease in men: A nested case-control study
- 11 July 1997
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 132 (1), 77-84
- https://doi.org/10.1016/s0021-9150(97)00071-3
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Elevated Plasma Lipoprotein(a) and Coronary Heart Disease in Men Aged 55 Years and YoungerJAMA, 1996
- Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged menThe American Journal of Cardiology, 1996
- Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)European Journal of Clinical Investigation, 1994
- Lipoprotein(a) Levels and Risk of Coronary Heart Disease in MenJAMA, 1994
- Apo(a) isoforms predict risk for coronary heart disease. A study in six populations.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Predictive value of apolipoproteins in a prospective survey of coronary artery disease in menThe American Journal of Cardiology, 1992
- Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.BMJ, 1990
- The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosisDependence on serum LDL levelsAtherosclerosis, 1986
- Lipoprotein Lp(a) and the risk for myocardial infarctionAtherosclerosis, 1981
- Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart diseaseClinical Genetics, 1974